aap Implantate AG
aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight plates, knee, elbow, wrist, and shoulder. It also provides hole screws and Repro Bone materials. The company sells its products directly to hospitals, purchasing groups, and hospital… Read more
aap Implantate AG (AAQ1) - Total Assets
Latest total assets as of June 2025: €13.98 Million EUR
Based on the latest financial reports, aap Implantate AG (AAQ1) holds total assets worth €13.98 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
aap Implantate AG - Total Assets Trend (2016–2024)
This chart illustrates how aap Implantate AG’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
aap Implantate AG - Asset Composition Analysis
Current Asset Composition (December 2024)
aap Implantate AG's total assets of €13.98 Million consist of 56.1% current assets and 43.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 13.1% |
| Accounts Receivable | €1.95 Million | 12.3% |
| Inventory | €4.09 Million | 25.8% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.88 Million | 11.9% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how aap Implantate AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: aap Implantate AG's current assets represent 56.1% of total assets in 2024, a decrease from 65.4% in 2016.
- Cash Position: Cash and equivalents constituted 13.1% of total assets in 2024, down from 37.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, a decrease from 17.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 25.8% of total assets.
aap Implantate AG Competitors by Total Assets
Key competitors of aap Implantate AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
aap Implantate AG - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - aap Implantate AG generates 0.77x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - aap Implantate AG is currently not profitable relative to its asset base.
aap Implantate AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.40 | 2.12 | 2.01 |
| Quick Ratio | 1.24 | 1.03 | 0.68 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €4.51 Million | € 4.76 Million | € 4.84 Million |
aap Implantate AG - Advanced Valuation Insights
This section examines the relationship between aap Implantate AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.97 |
| Latest Market Cap to Assets Ratio | 0.61 |
| Asset Growth Rate (YoY) | -8.4% |
| Total Assets | €15.84 Million |
| Market Capitalization | $9.65 Million USD |
Valuation Analysis
Below Book Valuation: The market values aap Implantate AG's assets below their book value (0.61 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: aap Implantate AG's assets decreased by 8.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for aap Implantate AG (2016–2024)
The table below shows the annual total assets of aap Implantate AG from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €15.84 Million | -8.36% |
| 2023-12-31 | €17.28 Million | -14.56% |
| 2022-12-31 | €20.23 Million | -11.88% |
| 2021-12-31 | €22.95 Million | +16.48% |
| 2020-12-31 | €19.71 Million | -25.04% |
| 2019-12-31 | €26.29 Million | -37.74% |
| 2018-12-31 | €42.22 Million | -16.34% |
| 2017-12-31 | €50.47 Million | -20.96% |
| 2016-12-31 | €63.85 Million | -- |